Q-VE-OPh (Negative Control)

Catalog number: AG-CP3-0007-M001
Brand: AdipoGen Life Sciences
Packing: 1 mg
Price: € 165.00
Expected delivery time: 7 days
Quantity:
Chemical Structure
Chemical Structure...

Product specifications for - Q-VE-OPh (Negative Control)

Overview: 
Product group: Assays
Category: Standards / controls
Properties: 
Purity: >95% (TLC)
Molecular Formula: C27H27F2N3O6
Molecular weight: 527.5
Datasheet: Datasheet
  Research Use Only
UNSPSC: 41116135
Storage instructions: 2-¦C to 8-¦C, -20-¦C
Scientific information: 
Scientific info: Cell permeable, non-toxic negative control for the caspase inhibitor Q-VD-OPh (Prod. No. AG-CP3-0006). Stable in aqueous environment. Several folds less inhibitory activity than Q-VD-OPh. Perfect for both in vitro and in vivo studies. - Chemical. Formula: C27H27F2N3O6. MW: 527.5. Synthetic. Cell permeable, non-toxic negative control for the caspase inhibitor Q-VD-OPh (Prod. No. AG-CP3-0006). Stable in aqueous environment. Several folds less inhibitory activity than Q-VD-OPh. Perfect for both in vitro and in vivo studies.
Safety information: 
MSDS: MSDS
Hazard information: Non-hazardous
Additional information: 
Synonyms: AG-CP3-0007-M001
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties: T.M. Caserta, et al.; Apoptosis 8, 345 (2003) Read more
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities: T.T. Rohn; Apoptosis 15, 1403 (2010) Read more
Q-VE-OPh, a Negative Control for O-Phenoxy-Conjugated Caspase Inhibitors: B. Southerland, et al.; J. Cell Death 3, 33 (2010) Read more
The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells: X. Chen-Deutsch, et al.; Leuk. Res. 36, 884 (2012) Read more